An Open-label, Single Dose, Parallel Design, Phase 1 Clinical Study of LCB01-0371
Clinical trial NCT02529241 · TERMINATED
Trial details
- NCT number
- NCT02529241
- Sponsor
- LigaChem Biosciences, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2015-12-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.